Search Results - "Kemaladewi, Dwi U."
-
1
Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease
Published in American journal of human genetics (07-03-2019)“…Gene-panel and whole-exome analyses are now standard methodologies for mutation detection in Mendelian disease. However, the diagnostic yield achieved is at…”
Get full text
Journal Article -
2
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
Published in Nature (London) (01-08-2019)“…Neuromuscular disorders are often caused by heterogeneous mutations in large, structurally complex genes. Targeting compensatory modifier genes could be…”
Get full text
Journal Article -
3
Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders
Published in American journal of human genetics (07-01-2016)“…Clustered regularly interspaced short palindromic repeat (CRISPR) has arisen as a frontrunner for efficient genome engineering. However, the potentially broad…”
Get full text
Journal Article -
4
Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
Published in Nature medicine (01-08-2017)“…An HDR-independent therapeutic genome-editing approach corrected the splice-site mutation in Lama2 in a mouse model of congenital muscular dystrophy type 1A,…”
Get full text
Journal Article -
5
Impaired polyamine metabolism causes behavioral and neuroanatomical defects in a mouse model of Snyder-Robinson Syndrome
Published in Disease models & mechanisms (01-06-2024)“…Snyder-Robinson Syndrome (SRS) is a rare X-linked recessive disorder caused by a mutation in the SMS gene encoding spermine synthase and aberrant polyamine…”
Get full text
Journal Article -
6
Antisense-oligonucleotide mediated exon skipping in activin-receptor-like kinase 2: inhibiting the receptor that is overactive in fibrodysplasia ossificans progressiva
Published in PloS one (04-07-2013)“…Fibrodysplasia ossificans progressiva (FOP) is a rare heritable disease characterized by progressive heterotopic ossification of connective tissues, for which…”
Get full text
Journal Article -
7
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model
Published in Neurobiology of disease (01-02-2011)“…Abstract Duchenne Muscular Dystrophy (DMD) is an X-linked lethal muscle wasting disease characterized by muscle fiber degeneration and necrosis. The…”
Get full text
Journal Article -
8
Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor
Published in Molecular therapy. Nucleic acids (01-04-2014)“…Duchenne muscular dystrophy (DMD) is caused by lack of functional dystrophin and results in progressive myofiber damage and degeneration. In addition, impaired…”
Get full text
Journal Article -
9
Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
Published in BMC medical genomics (20-04-2011)“…Myostatin is a potent muscle growth inhibitor that belongs to the Transforming Growth Factor-β (TGF-β) family. Mutations leading to non functional myostatin…”
Get full text
Journal Article -
10
Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides
Published in Molecular therapy. Nucleic acids (01-01-2014)“…Dupuytren's disease (DD) is a benign fibroproliferative disease of the hand. It is characterized by the excessive production of extracellular matrix (ECM)…”
Get full text
Journal Article -
11
Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease
Published in American journal of human genetics (02-05-2019)Get full text
Journal Article -
12
Exon Snipping in Duchenne Muscular Dystrophy
Published in Trends in molecular medicine (01-03-2016)“…Duchenne muscular dystrophy (DMD) is a life-limiting neuromuscular disorder caused by mutations in the DMD gene encoding dystrophin. We discuss very recent…”
Get full text
Journal Article -
13
Cell‐type specific regulation of myostatin signaling
Published in The FASEB journal (01-04-2012)“…The transforming growth factor (TGF)‐β family member myostatin is an important regulator of myoblast, adipocyte, and fibroblast growth and differentiation, but…”
Get full text
Journal Article -
14
Early-career researchers in the time of COVID-19: Benefits of structural support
Published in Cell stem cell (06-05-2021)“…COVID-19 shutdowns have had detrimental impacts on new labs, but thoughtful support from institutions and funding bodies may alleviate key pressures and…”
Get full text
Journal Article -
15
Introductions to the Community: Early-Career Researchers in the Time of COVID-19
Published in Cell stem cell (04-06-2020)“…COVID-19 has unfortunately halted lab work, conferences, and in-person networking, which is especially detrimental to researchers just starting their labs…”
Get full text
Journal Article -
16
559. Spell Checking Nature: A Therapeutic Use of the CRISPR/Cas9 System in Duchenne Muscular Dystrophy
Published in Molecular therapy (01-05-2015)Get full text
Journal Article -
17
Antisense-Oligonucleotide Mediated Exon Skipping in Activin-Receptor-Like Kinase 2: Inhibiting the Receptor That Is Overactive in Fibrodysplasia Ossificans Progressiva. e69096
Published in PloS one (01-07-2013)“…Fibrodysplasia ossificans progressiva (FOP) is a rare heritable disease characterized by progressive heterotopic ossification of connective tissues, for which…”
Get full text
Journal Article -
18
Targeting TGF-[beta] Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-[beta] Type I Receptor
Published in Molecular therapy. Nucleic acids (01-04-2014)“…Duchenne muscular dystrophy (DMD) is caused by lack of functional dystrophin and results in progressive myofiber damage and degeneration. In addition, impaired…”
Get full text
Journal Article -
19
Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGF[beta] Type 1 Receptor Modulation by Antisense Oligonucleotides
Published in Molecular therapy. Nucleic acids (01-01-2014)“…Dupuytren's disease (DD) is a benign fibroproliferative disease of the hand. It is characterized by the excessive production of extracellular matrix (ECM)…”
Get full text
Journal Article